SCHEMBL5830307

SCHEMBL5830307

C=CC(=O)NC(=O)CCCCCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 6/20 0.58
ZDHHC20 Q5W0Z9 1/20 0.56
ZDHHC2 Q9UIJ5 1/20 0.56
HSP90AA1 P07900 1/20 0.53
MEN1 O00255 1/20 0.53
MAPK1 P28482 1/20 0.53
KMT2A Q03164 1/20 0.53
POLB P06746 1/20 0.47
POLA1 P09884 1/20 0.47
ALDH1A1 P00352 2/20 0.46
MAPT P10636 1/20 0.46
CES2 O00748 3/20 0.45
CES1 P23141 3/20 0.45
TSHR P16473 2/20 0.44
TRPA1 O75762 1/20 0.44
THRA P10827 1/20 0.44
THRB P10828 1/20 0.44
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
GPR84 Q9NQS5 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3211607 1.00 FAAH (0.58) FAAHZDHHC20ZDHHC2HSP90AA1MEN1
SCHEMBL4919984 1.00 FAAH (0.58) FAAHZDHHC20ZDHHC2HSP90AA1MEN1
SCHEMBL15129341 1.00 FAAH (0.58) FAAHZDHHC20ZDHHC2HSP90AA1MEN1
SCHEMBL7710247 1.00 FAAH (0.58) FAAHZDHHC20ZDHHC2HSP90AA1MEN1
SCHEMBL7710254 1.00 FAAH (0.58) FAAHZDHHC20ZDHHC2HSP90AA1MEN1
SCHEMBL2931470 0.98 FAAH (0.55) FAAHZDHHC20ZDHHC2HSP90AA1MEN1
SCHEMBL2933508 0.92 ZDHHC20 (0.50) FAAHZDHHC20ZDHHC2HSP90AA1MEN1
SCHEMBL7718955 0.92 HRH3 (0.55) FAAHMEN1KMT2APOLBMAPT
SCHEMBL5066977 0.92 HRH3 (0.55) FAAHMEN1KMT2APOLBMAPT
Propene SCHEMBL29262705 0.84 FAAH (0.61) FAAHHSP90AA1MEN1MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7048917-B1 Fat-binding polymers GENZYME CORPORATION (US) 2006-05-23 US disclosed
US-6726906-B1 ORALLY ADMINISTERED POLY(N,N-DI(2,3-DIHYDROXYPROPYL) ALLYLAMINE)HYDROCHLORIDE AND TETRAHYDROLIPSTATIN LIPASE INHIBITOR; HYPERTRIGLYCERIDEMIA; SIDE EFFECT REDUCTION GENZYME CORPORATION 2004-04-27 US disclosed
US-6299868-B1 FACILITATES THE REMOVAL OF FAT FROM THE BODY PRIOR TO DIGESTION, WITH MINIMAL SIDE EFFECTS AND LOW TOXICITY; FOR THERAPY OF OBESITY, STEATORRHEA, HYPERTRIGLYCERIDEMIA IN MAMMALS GELTEX PHARMACEUTICALS, INC. 2001-10-09 US disclosed